Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Liquidity: $11,590M in FY2025, down 13.9% from a year earlier.
Latest, FY2025
11,590
Period ended Dec 31, 2025
Change on a year earlier
-13.9%
13,457 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Total liquidity | 8 975 | 11 590 | 9 753”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Liquidity ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,590 | -13.9% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 13,457 | -6.7% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 14,428 | -23.8% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 18,930 | -33.2% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 28,329 | +145.0% | Novartis Form 6-K (0001370368-22-000077) ↗ |
| FY2020 | Dec 31, 2020 | 11,563 | -27.6% | Novartis Form 6-K (0001370368-21-000072) ↗ |
| FY2019 | Dec 31, 2019 | 15,964 | +68.3% | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2018 | Dec 31, 2018 | 9,485 | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Total Liquidity ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/nd-total-liquidity
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.